No more excuses: viral hepatitis can be eliminated.
WHO Collaborating Centre for Viral Hepatitis VIDRL, Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia; Coalition to Eradicate Viral Hepatitis in Asia Pacific, 058416 Singapore. Electronic address: stephen.locarnini@vidrl.org.au.
Stephen
S
Locarnini
Hepatitis Research Centre, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Coalition to Eradicate Viral Hepatitis in Asia Pacific, 058416 Singapore.
Ding-Shinn
DS
Chen
Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Coalition to Eradicate Viral Hepatitis in Asia Pacific, 058416 Singapore.
Kenji
K
Shibuya
D000998:Antiviral Agents / Q000627:therapeutic use*; D060740:Disease Eradication; D006292:Health Priorities; D006525:Hepatitis, Viral, Human / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D014480:United Nations; D014761:Viral Hepatitis Vaccines / Q000627:therapeutic use*; D014944:World Health Organization
D000998:Antiviral Agents; D014761:Viral Hepatitis Vaccines